T. Rowe Price Associates’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06M | Buy |
|
|||||
|
2025
Q1 | $956K | Buy |
|
|||||
|
2024
Q4 | $690K | Sell |
|
|||||
|
2024
Q3 | $3.94M | Buy |
|
|||||
|
2024
Q2 | $275K | Buy |
|
|||||
|
2024
Q1 | $240K | Buy |
|
|||||
|
2023
Q4 | $253K | Buy |
|
|||||
|
2023
Q3 | $240K | Sell |
|
|||||
|
2023
Q2 | $571K | Buy |
|
|||||
|
2023
Q1 | $704K | Buy |
|
|||||
|
2022
Q4 | $610K | Sell |
|
|||||
|
2022
Q3 | $764K | Buy |
|
|||||
|
2022
Q2 | $651K | Buy |
|
|||||
|
2022
Q1 | $425K | Buy |
|
|||||
|
2021
Q4 | $441K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $6.03M | Sell |
|
|||||
|
2017
Q3 | $8.63M | Buy |
|
|||||
|
2017
Q2 | $6.69M | Sell |
|
|||||
|
2017
Q1 | $9.24M | Sell |
|
|||||
|
2016
Q4 | $12.1M | Sell |
|
|||||
|
2016
Q3 | $19M | Buy |
|
|||||
|
2016
Q2 | $12.6M | Sell |
|
|||||
|
2016
Q1 | $9.89M | Buy |
|
|||||
|
2015
Q4 | $13.9M | Sell |
|
|||||
|
2015
Q3 | $14.6M | Sell |
|
|||||
|
2015
Q2 | $24.8M | Hold |
|
|||||
|
2015
Q1 | $17.9M | Buy |
|